­

Testicular Cancer and the Link to Marijuana Use

Research is showing a direct link between pot use and testicular cancer in men 15 to 30 years of age. Victoria Cortessis, PhD, Norris Comprehensive Cancer Center and departments of Preventive Medicine and Obstetrics and Gynaecology at the Keck School of Medicine of the University of Southern California, recently made the link between [...]

New Melanoma Drug Boosts Survival Rates

Patients with advanced skin cancer can now hope to extend life. The new treatment unveiled at a cancer meeting in Chicago has been praised by the cancer care fraternity. Vemurafenib is an experimental drug that attacks the root of the cancerous source. Developed by Plexxikon and Roche/Genentech, it targets a genetic mutation that causes melanoma [...]

New Drug Target in Breast Cancer

Researchers at the Imperial College London have now identified a novel protein –LMTK3, which is involved in the process of drug resistance in breast cancer. This protein can purportedly act as a target for new treatments. Breast cancer is the most common cancer in the UK and affects around 46,000 women annually. Although anti-oestrogen drugs [...]

Reasons for Breast Cancer Among Men

Breast cancer is very rare in men although the symptoms, diagnosis and treatment are a bit similar to women with breast cancer. According to the U.S. National Cancer Institute (1), breast cancer in men occurs in about 1 percent of breast cancer cases. In the UK, there are around 300 men diagnosed annually, compared with [...]

New Drug to Fight Chronic Myeloid Leukemia

A new drug has shown a lot of potential to fight chronic myeloid leukemia (CML), which has become resistant to regular treatment. According to the study conducted by the Tufts Medical Center, the drug named DCC-2036 decreased the mutant enzyme, BCR-ABL1 in human leukemia cells. However, in mice, the drug wiped out the cancer cells [...]

Pfizer’s New Drug Slows Pancreatic Tumors

Pfizer's experimental drug, CP- 870,893 slowed down pancreatic cancer significantly. The treatment tricks the immune system and shrinks pancreatic tumors by targeting the tissue around the cancer mass instead of the malignant cells. The method was tested on lab mice and twenty-one human patients. The team, made up of laboratory scientists and clinical doctors, embarked [...]

Leflunomide to Fight Skin Cancer

The drug leflunomide, which is currently being used to treat rheumatoid arthritis, could now help to fight melanoma - the deadliest form of skin cancer. After conducting the ability to affect the development of pigment cells in tadpoles, scientists seemed to have found a way to deal with melanoma. Why tadpoles you may ask? The [...]

Ipilimumab – New Melanoma Treatment

Ipilimumab is a new treatment for advanced melanoma that has generated a lot of excitement.  While a step in the right direction, it has limited efficacy and still has to be determined as to its best use. Considering that only 5-10% of people are alive in 5 years when they have stage IV melanoma, any [...]

Olaparib, a PARP Inhibitor

Olaparib is a member of the poly-ADP ribose polymerase  (PARP) inhibitors and may work as a treatment for certain types of breast, ovarian and prostate cancer.  PARP is involved in repairing DNA damage.  By inhibiting PARP, rapidly growing cells such as those in cancer may accumulate damage or be more susceptible to death from traditional [...]

Dendreon’s Provenge for Prostate Cancer

  Provenge is a promising new therapy made by Dendreon for certain types of prostate cancer.  It has shown strong efficacy to date in several studies, but concerns about how it is made played a large role in the FDA asking for more data on it in 2007.  It is up for another [...]